Children With Autism and Social Interaction Processing

May 13, 2026 updated by: Shan Gao, University of Electronic Science and Technology of China

Characteristics of Gaze Behavior in Social Interaction Processing of Children With Autism

Attention allocation in ASD vs. TD children viewing social/non-social interactions by adult/child models, and the dynamics of social attention.

Study Overview

Status

Completed

Conditions

Detailed Description

Participants: ASD group: 30 children; TD group: 29 children; age- and sex-matched.

Apparatus: Non-invasive eye tracker (Tobii Pro Spectrum). Stimuli: Eight 60-second videos (4 with child models, 4 with adult models). Questionnaires/Assessments: SRS, AQ, SCQ, ADOS-2, PPVT. Experimental design: A 2 (group: TD, ASD) × 2 (model type: adult, child) × 2 (context: interactive, non-interactive) × 2 (phase: baseline, test) mixed design.

Task: Free viewing of eight videos presented in random order.

Study Type

Observational

Enrollment (Actual)

59

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • China
    • Sichuan
      • Chengdu, Sichuan, China, 611731
        • School of Foreign Languages, University of Electronic Science and Technology of China

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

In this experiment, 47 children with autism spectrum disorder (ASD) were recruited from an autism rehabilitation institution in Chengdu, and 37 typically developing (TD) children were recruited from a kindergarten in Shehong City. All ASD participants were clinically diagnosed with ASD by hospital physicians according to the DSM-5 criteria. Each participant underwent SRS,AQ,and SCQ tests.

Description

Inclusion Criteria:

- For ASD group: confirmed clinical diagnosis of Autism Spectrum Disorder(DSM-5/ADOS-2) For TD group：TD children without any developmental or neurological disorders Both groups：Normal or corrected-to-normal vision，no color vision deficiencies，and legal guardian provided written informed consent

Exclusion Criteria:

- TD group: meet the study's group-specific screening cutoffs on SRS, SCQ or AQ ASD group：Failure to meet the study's group-specific screening cutoffs on ADOS-2 Both groups：Known genetic syndromes，significant hearing loss or uncorrectable visual impairment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Autism Spectrum Disorder (ASD) Group
Typically Developing (TD) Group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportion of total fixation duration on human faces, context, activity areas
Time Frame: During the full 8 minutes video presentation
Proportion of total fiaxtion duration on human faces, context, activity areas was calculated as (total fixation duration on AOIs/ total fixation duration on the screen).
During the full 8 minutes video presentation
Number of saccades on human faces, context, activity areas
Time Frame: During the full 8 minutes video presentation
The number of saccades on human faces, context, activity areas occurring during an interval.
During the full 8 minutes video presentation
Social Prioritization Score on human faces, context, activity areas
Time Frame: During the full 8 minutes video presentation
The difference in the proportion of fixation time between social and non-social interaction information.
During the full 8 minutes video presentation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Electronic Science and Technology of China

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 28, 2024

Primary Completion (Actual)

March 23, 2025

Study Completion (Actual)

October 12, 2025

Study Registration Dates

First Submitted

May 6, 2026

First Submitted That Met QC Criteria

May 13, 2026

First Posted (Actual)

May 19, 2026

Study Record Updates

Last Update Posted (Actual)

May 19, 2026

Last Update Submitted That Met QC Criteria

May 13, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • UESTC-GazeLab-05

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder (ASD)

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe